» Articles » PMID: 35615576

Capsaicin Prevents Contrast-Associated Acute Kidney Injury Through Activation of Nrf2 in Mice

Overview
Publisher Wiley
Date 2022 May 26
PMID 35615576
Authors
Affiliations
Soon will be listed here.
Abstract

Capsaicin, a transient receptor potential vanilloid 1 channel agonist, possesses antioxidative properties through activating nuclear factor-erythroid 2-related factor 2 (Nrf2). As oxidative stress is a major contributor to the development of contrast-associated acute kidney injury (CA-AKI), we investigated the protective effect of capsaicin against CA-AKI via Nrf2. C57BL/6J mice were treated with dehydration and iodixanol to establish the model of CA-AKI. For pretreatment, capsaicin (0.3 mg/kg) was given via intraperitoneal injection one hour before iodixanol injection. Nrf2-specific siRNA was given through the tail vein to knock down Nrf2. The CA-AKI mouse model had remarkable mitochondrial fragmentation and dysfunction and apoptosis of tubular cells, overproduction of superoxide in renal tubules, increased renal malondialdehyde, tubular epithelial cell injury, and renal dysfunction. Importantly, pretreatment with capsaicin significantly ameliorated tubular cell injury and renal dysfunction with decreased superoxide, renal malondialdehyde, and apoptotic tubular cells and improved mitochondrial morphology and function in the CA-AKI mouse model. The expression of Nrf2 was increased in the kidney from the CA-AKI mouse model and was further enhanced by capsaicin. Administration of siRNA through the tail vein successfully decreased Nrf2 expression in the kidney, and knockdown of Nrf2 by siRNA abolished the beneficial effects of capsaicin on CA-AKI. The present study demonstrated a protective effect of capsaicin pretreatment against CA-AKI via Nrf2.

Citing Articles

Signal pathways involved in contrast-induced acute kidney injury.

Deng K, Pei M, Li B, Yang N, Wang Z, Wan X Front Physiol. 2024; 15:1490725.

PMID: 39655278 PMC: 11625813. DOI: 10.3389/fphys.2024.1490725.


Sodium selenite attenuates inflammatory response and oxidative stress injury by regulating the Nrf2/ARE pathway in contrast-induced acute kidney injury in rats.

Xiang H, Tan Q, Zhang Y, Wu Y, Xu Y, Hong Y BMC Nephrol. 2024; 25(1):226.

PMID: 39009991 PMC: 11247789. DOI: 10.1186/s12882-024-03657-0.


NRF2 in kidney physiology and disease.

Bondi C, Hartman H, Tan R Physiol Rep. 2024; 12(5):e15961.

PMID: 38418382 PMC: 10901725. DOI: 10.14814/phy2.15961.


Spice Up Your Kidney: A Review on the Effects of Capsaicin in Renal Physiology and Disease.

Musolino M, DAgostino M, Zicarelli M, Andreucci M, Coppolino G, Bolignano D Int J Mol Sci. 2024; 25(2).

PMID: 38255865 PMC: 10815060. DOI: 10.3390/ijms25020791.


Research progress on animal models of contrast-induced acute kidney injury.

Deng K, Pei M, Chen Y Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023; 48(4):594-600.

PMID: 37385622 PMC: 10930254. DOI: 10.11817/j.issn.1672-7347.2023.220608.


References
1.
Jadeja R, Upadhyay K, Devkar R, Khurana S . Naturally Occurring Nrf2 Activators: Potential in Treatment of Liver Injury. Oxid Med Cell Longev. 2017; 2016:3453926. PMC: 5215260. DOI: 10.1155/2016/3453926. View

2.
Kassmann M, Harteneck C, Zhu Z, Nurnberg B, Tepel M, Gollasch M . Transient receptor potential vanilloid 1 (TRPV1), TRPV4, and the kidney. Acta Physiol (Oxf). 2012; 207(3):546-64. DOI: 10.1111/apha.12051. View

3.
Yu S, Ma S, Wang D . Ablation of TRPV1-positive nerves exacerbates salt-induced hypertension and tissue injury in rats after renal ischemia-reperfusion via infiltration of macrophages. Clin Exp Hypertens. 2020; 43(3):254-262. PMC: 7858237. DOI: 10.1080/10641963.2020.1860078. View

4.
Zhao X, Zhang E, Ren X, Bai X, Wang D, Bai L . Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia-reperfusion-induced kidney injury via the JAK/STAT pathway. Biol Res. 2020; 53(1):28. PMC: 7333427. DOI: 10.1186/s40659-020-00297-0. View

5.
Yang Y, Wang D, Wan J, Ran F, Yang L, Chen S . The role of transient receptor potential ankyrin 1 in age-related endothelial dysfunction. Exp Gerontol. 2021; 154:111517. DOI: 10.1016/j.exger.2021.111517. View